Journals / Ortadoğu Tıp Dergisi / 2018 / Cilt: 10 - Sayı: 4

The strong relationship between disease severity and thiol-disulphide homeostasis in patients with restless legs syndrome

Huzursuz bacak sendromlu hastalarda hastalık şiddeti ve tiyol-disülfid homeostazı arasındaki güçlü ilişki

Pages
436–443
Publication Date
2018-12-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Strong correlations between the IRLSSG Severity Scale and thiol-disulphide homeostasis parameters indicate that homeostasis may have a role in the pathogenesis of the Primary RLS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study was conducted to investigate thiol-disulphide homeostasis, a novel oxidative stress marker in primary restless legs syndrome (RLS) patients.Material and Method: Thirty-eight patients and 43 healthy subjects were included in the study.
📊
Key Findings & Data:Diagnosis of RLS was based on the criteria proposed by the International Restless Legs Syndrome Study Group (IRLSSG), and RLS severity was assessed using the IRLSSG Severity Scale.Results: Serum native thiol and total thiol levels were significantly lower (p< 0.001; p= 0.007, respectively) while disulphide and disulphide/native thiol percent ratio levels significantly higher (p= 0.017; p< 0.001, respectively), in patients with RLS compared with control group.
💡
Conclusion & Impact:Strong correlations between the IRLSSG Severity Scale and thiol-disulphide homeostasis parameters indicate that homeostasis may have a role in the pathogenesis of the Primary RLS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Disulphide · oxidative stress · restless legs syndrome

Abstract

Objective: This study was conducted to investigate thiol-disulphide homeostasis, a novel oxidative stress marker in primary restless legs syndrome (RLS) patients.Material and Method: Thirty-eight patients and 43 healthy subjects were included in the study. Serum native thiol, total thiol, disulphide and disulphide / native thiol percent ratio levels were measured by using a novel automated method. Diagnosis of RLS was based on the criteria proposed by the International Restless Legs Syndrome Study Group (IRLSSG), and RLS severity was assessed using the IRLSSG Severity Scale.Results: Serum native thiol and total thiol levels were significantly lower (p< 0.001; p= 0.007, respectively) while disulphide and disulphide/native thiol percent ratio levels significantly higher (p= 0.017; p< 0.001, respectively), in patients with RLS compared with control group. Significant correlations were found between the IRLSSG Severity Scale and thiol-disulphide homeostasis parameters (r= -0.56, p< 0.001 for native thiol; r= -0.51, p< 0.001 for total thiol; r= 0.37, p= 0.020 for disulphide and r= 0.60, p< 0.001 for disulphide/native thiol percent ratio). Conclusions: Decreased native thiol, increased disulphide levels and increased disulphide/native thiol percent ratio show that thiol-disulphide balance shifted to the oxidation side. Strong correlations between the IRLSSG Severity Scale and thiol-disulphide homeostasis parameters indicate that homeostasis may have a role in the pathogenesis of the Primary RLS.

Özet

Amaç: Bu çalışma, primer huzursuz bacak sendromu (RLS) hastalarında yeni bir oksidatif stres belirteci olan tiyol-disülfid homeostazisini araştırmak amacıyla yapıldı.Gereç ve Yöntem: Otuz sekiz hasta ve 43 sağlıklı birey çalışmaya alındı. Serum nativ tiyol, total tiyol, disülfit ve disülfid / nativ tiyol oranları yeni bir otomatik yöntem kullanılarak ölçülmüştür. RLS tanısı Uluslararası Huzursuz Bacak Sendromu Çalışma Grubu (IRLSSG) tarafından önerilen kriterlere gore konuldu ve RLS şiddeti IRLSSG Şiddet Ölçeği kullanılarak değerlendirildi.Bulgular: Serum nativ tiyol ve total tiyol düzeyleri anlamlı derecede düşük (sırasıyla p<0.001; p=0.007), disülfid ve disülfid / nativ tiyol oranı anlamlı olarak daha yüksekti (sırasıyla p=0.017; p<0.001). RLS kontrol grubu ile karşılaştırıldı. IRLSSG Önem Ölçeği ve tiyol-disülfid homeostasisi parametreleri arasında anlamlı korelasyonlar bulundu (r=-0.56, nativ tiyol için p<0.001; total tiyol için r=-0.51, p<0.001; disülfid için r=0.37, p=0.020); r=0.60, disülfid / nativ tiyol yüzdesi oranı için p<0.001). Sonuçlar: Azalmış nativ tiyol, artan disülfid seviyeleri ve artmış disülfid / nativ tiyol oranı, tiyol-disülfür dengesinin oksidasyon tarafına kaydığını göstermektedir. IRLSSG Önem Ölçeği ve tiyol-disülfid homeostasisi parametreleri arasındaki güçlü korelasyonlar, homeostazın primer RLS'nin patogenezinde rol oynayabileceğini göstermektedir.

🔖

Cite This Article

NEŞELİOĞLU, S., EREN, Y., DİRİK, E. B., YURT, E. F., ERDOGAN, S., DENİZ, O., EREL, Ö. (2018). The strong relationship between disease severity and thiol-disulphide homeostasis in patients with restless legs syndrome. Ortadoğu Tıp Dergisi, Cilt: 10 - Sayı: 4, 436–443. https://ajindex.com/articles/30826

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Koo, B.B., K. Bagai, and A.S. Walters, Restless legs syndrome: current concepts about disease pathophysiology. Tremor and Other Hyperkinetic Movements, 2016. 6
  2. Kim, J. and A.G. Hartzema, Adherence and persistence to ropinirole, pramipexole, and gabapentin in patients with newly diagnosed restless legs syndrome. Sleep medicine, 2018. 44: p. 45-52
  3. Akpinar, S., Restless legs syndrome treatment with dopaminergic drugs. Clinical neuropharmacology, 1987. 10(1): p. 69-79
  4. Iranzo, A., C.L. Comella, J. Santamaria, and W. Oertel, Restless legs syndrome in Parkinson's disease and other neurodegenerative diseases of the central nervous system. Movement disorders: official journal of the Movement Disorder Society, 2007. 22(S18): p. S424-S430
  5. Mitchell, U.H., J.D. Obray, E. Hunsaker, B.T. Garcia, T.J. Clarke, S. Hope, et al., Peripheral Dopamine in restless legs syndrome. Frontiers in neurology, 2018. 9: p. 155
  6. Baskol, G., S. Korkmaz, F. Erdem, A. Caniklioglu, M. Kocyigit, and M. Aksu, Assessment of nitric oxide, advanced oxidation protein products, malondialdehyde, and thiol levels in patients with restless legs syndrome. Sleep medicine, 2012. 13(4): p. 414-418
  7. Erel, O. and S. Neselioglu, A novel and automated assay for thiol/disulphide homeostasis. Clinical biochemistry, 2014. 47(18): p. 326-332
  8. Gumusyayla, S., G. Vural, H. Bektas, O. Deniz, S. Neselioglu, and O. Erel, A novel oxidative stress marker in patients with Alzheimer’s disease: dynamic thiol–disulphide homeostasis. Acta neuropsychiatrica, 2016. 28(6): p. 315-320
  9. Vural, G., S. Gumusyayla, H. Bektas, O. Deniz, M. Alisik, and O. Erel, Impairment of dynamic thiol–disulphide homeostasis in patients with idiopathic Parkinson’s disease and its relationship with clinical stage of disease. Clinical neurology and neurosurgery, 2017. 153: p. 50-55
  10. Gumusyayla, S., G. Vural, H. Bektas, S. Neselioglu, O. Deniz, and O. Erel, A novel oxidative stress marker in migraine patients: dynamic thiol–disulphide homeostasis. Neurological Sciences, 2016. 37(8): p. 1311-1317
  11. Kundi, H., M. Gok, M. Cetin, E. Kiziltunç, C. Topcuoglu, S. Neşelioğlu, et al., Association of thiol disulfide homeostasis with slow coronary flow. Scandinavian Cardiovascular Journal, 2016. 50(4): p. 213-217
  12. Altiparmak, I.H., M.E. Erkus, H. Sezen, R. Demirbag, Z. Kaya, Y. Sezen, et al., Evaluation of thiol levels, thiol/disulfide homeostasis and their relation with inflammation in cardiac syndrome X. Coronary artery